Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...

NATICK, Mass.--(BUSINESS WIRE)--$ALUR--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss ...

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (ALUR), a pioneer in metabolically healthy weight loss, today announced initial results on the combination of the Allurion Program with low ...

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced initial results on the combination of the Allurion Program with ...

COLUMBUS, Ohio -- Ohio may start paying its small towns and villages to merge. A new bill at the statehouse would create a $25 million grant program to reward local governments that combine into one ...

Leuven, Belgium and Zeist, The Netherlands, Nov. 19, 2025 (GLOBE NEWSWIRE) -- P95 and Julius Clinical today announced that they have merged to form a leading global, full-service clinical research ...

Over the past decade, industry-sponsored clinical trial activity at UAB has grown steadily. To sustain and accelerate this momentum, the Clinical Trialist Development Program (CTDP) supports promising ...

Clinical Trial in Africa Finds Single-Dose Malaria Treatment Combining Four Existing Drugs as Effective as More Onerous Multi-Day, Multi-Dose Regimen Research advance from Gabon presented at the ...

Mark Zuckerberg and Priscilla Chan today announced the launch of a first-of-its-kind initiative combining frontier artificial intelligence and frontier biology to dramatically accelerate scientific ...

Purpose: Gout is a chronic disease caused by the deposition of monosodium urate crystals in joints and tissues. The Qifu Huazhuo (QFHZ) Formula has shown effectiveness and safety in the management of ...